• SENSEX 75,548.28
    -747.08 (--0.98%)
  • BANKNIFTY 51,597.35
    249.30 (+0.49%)
  • Tata Motors
    613.20 606.20(%)
  • Hindalco Inds.
    608.00 558.00(%)
  • Hind.Aeronautics
    4,205.05 3,045.95(%)
  • Reliance Industr
    1,192.85 1,156.00(%)
  • Mazagon Dock
    2,542.50 995.38(%)
  • Vedanta
    403.50 297.70(%)
  • Interglobe Aviat
    5,150.65 5,187.00(%)
  • HDFC Bank
    1,842.20 1,880.00(%)
  • Infosys
    1,451.50 1,359.10(%)
  • Bajaj Finance
    8,795.75 9,258.95(%)
  • ICICI Bank
    1,336.40 1,372.50(%)
  • Suzlon Energy
    55.00 37.95(%)
  • Vodafone Idea
    7.85 6.60(%)
  • TCS
    3,307.55 3,396.10(%)
  • Jio Financial
    222.30 198.60(%)
  • Angel One
    2,317.80 1,942.00(%)
  • Nippon ETF Liq.
    999.99 996.00(%)
  • O N G C
    225.70 215.20(%)
  • Kalyan Jewellers
    485.80 337.00(%)
  • IndusInd Bank
    675.40 605.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Biofil Chemicals & Pharmaceuticals Ltd Pharmaceuticals - Indian - Formulations

  • Systematix
  • BSE Code : 3284.0
  • ISIN : INE829A01014
43.09 -1 (-1.17%)
  • As on 04 Apr 2025 (EOD)

  • Today’s Low

    42.62

  • Today’s High

    44.59

  • Open

    43.60

  • Perv Close

    43.60

  • 52W Low

    40.40

  • 52W High

    91.87

Key Indicators

  • P/E(TTM)

    117.08

  • Mar.Cap (₹Cr.)

    70.11

  • Div & Yield %

    0.00

  • Book Value(₹)

    11.30

  • Debt-Equity Ratio

    -1.17

  • AGM Date

    03-Apr-2025

  • EPS

    0.37

  • P/E Ratio

    117.08

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    70.11

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    16.27

  • BV (₹)

    11.30

  • Sales( ₹ in Cr.)

    40.04

  • NP (in Cr.)

    0.71

  • NP Var(%)

    27.0

  • Div%

    0.0

  • CPS (₹)

    0.70

  • EPS (₹)

    0.40

  • Traded Value (₹ in Lakhs)

    70.48

  • 52 Week High

    91.87

  • 52 Week Low

    40.40

  • Price BSE

    43.0

  • Price NSE

    43.00

  • Market Capital( in Cr.)

    70.48

  • P/C Ratio

    63.10

  • P/E Ratio

    98.60

  • Price Vs.BV

    0.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 40.04 30.04 22.38 35.75 29.69 23.13
Excise Duty 40.04 30.04 21.82 33.95 27.39 21.50
Net Sales 40.04 30.04 22.38 35.75 29.69 23.13
Other Income 0.49 0.10 0.15 0.80 0.17 0.10
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 40.53 30.13 22.53 36.55 29.86 23.23
EXPENDITURE :
Raw Materials 40.04 30.04 21.82 33.95 27.39 21.50
Power & Fuel Cost 40.04 30.04 21.82 33.95 27.39 21.50
Employee Cost 0.67 0.62 0.79 0.75 0.86 0.89
Other Manufacturing Expenses 0.11 0.08 0.05 0.08 0.03 0.02
Selling & Administrative Expenses 0.54 0.41 0.42 0.43 0.84 0.81
Miscellaneous Expenses 0.11 0.08 0.05 0.08 0.03 0.02
Less : Pre-operative Expenses Capitalised :
Total Expenditure 39.66 29.34 21.52 34.63 28.40 22.63
Operating Profit 0.39 0.33 0.33 0.46 0.82 0.39
Interest 0.04 0.04 0.04 0.07 0.12 0.16
Gross Profit 0.87 0.79 1.01 1.92 1.46 0.60
Depreciation 0.40 0.43 0.43 0.41 0.41 0.37
Profit Before Tax 0.87 0.79 1.01 1.92 1.46 0.60
Tax 0.24 0.23 0.27 0.33 0.25 0.12
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.09 0.01 0.04 0.35 0.00 0.00
Reported Net Profit 0.71 0.56 0.70 1.24 1.21 0.48
Extraordinary Items 0.87 0.79 1.01 1.92 1.46 0.60
Adjusted Net Profit 0.71 0.56 0.70 1.24 1.21 0.48
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 0.71 0.56 0.70 1.24 1.21 0.48
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.44 0.34 0.44 0.77 0.74 0.30
Book Value 0.00 0.00 0.00 0.00 0.00 0.00
Book Value(Adj)-Unit Curr 0.00 0.00 0.00 0.00 0.00 0.00

Shareholding Pattern

  • Promoter Group

    46.82%

  • Public Share Holding

    53.18%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 4,314,200 26.51 4,314,200 3
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,304,560 20.31 3,304,560 13
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 7,618,760 46.82 7,618,760 16
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 6,200 0.04 0 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 135 0.00 135 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 7,000 0.04 0 3
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 13,335 0.08 135 5
2] Non Institution
Bodies Corporate 2,038,635 12.53 1,941,935 87
Clearing Members 4,600 0.03 4,600 9
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 65,800 0.40 0 1
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 192,548 1.18 108,648 290
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 126,310 0.78 126,310 179
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 607,886 3.74 607,886 11
Individuals holding nominal share capital up to Rs. 1 lakh 5,605,826 34.45 5,008,726 25,515
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 100 0.00 0 1
Others 0 0.00 0 0
Sub Total 8,641,705 53.10 7,798,105 26,093
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 16,273,800 100.00 15,417,000 26,114

Company Background

Biofil Chemicals & Pharmaceuticals LtdPharmaceuticals - Indian - Formulations

  • Biofil Chemicals & Pharmaceuticals Ltd
  • BSE Code : 3284.0
  • ISIN : INE829A01014

  • Incorporation Year

    1985

  • Registered Office

    11/12 Sector E Sanwer Road
    Sanwer Road Industrial Area, Indore,
    Madhya Pradesh-452015

  • Telephone

    91-731-2426700

  • FAX

    91-731-2420926

  • Chairman

    Ramesh Shah

  • Managing Director

    Ramesh Shah

  • Company Secretary

  • Auditor

    Maheshwari & Gupta

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Ankit Consultancy Pvt Ltd
    Plot No. 60,
    Electronic Complex,Pardeshipura
    Mumbai - Indore - 452010

Biofil Chemicals & Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Biofil Chemicals 43.32 40.53 40.04 117.08 1.81
Abbott India 29,940.35 6,097.18 5,848.91 47.68 44.71
Astrazeneca Phar 8,092.00 1,330.33 1,295.53 208.61 33.26
P & G Health Ltd 5,295.80 1,166.89 1,151.26 37.16 39.76
Glaxosmi. Pharma 2,857.90 3,530.73 3,407.25 56.83 44.44
Cipla 1,495.15 17,645.00 16,574.34 25.63 20.10
Amrutanjan Healt 666.30 437.58 421.23 39.06 20.84
Fermenta Biotec. 305.85 315.24 307.09 28.99 4.10
Guj. Themis Bio. 282.25 174.19 169.82 58.44 44.82
Bliss GVS Pharma 126.20 638.96 605.46 28.88 11.19
Ambalal Sarabhai 40.33 11.70 3.81 17.24 1.92